Clinical Trials Using Labetuzumab-SN-38 Immunoconjugate IMMU-130
Review the clinical trials studying labetuzumab-sn-38 immunoconjugate immu-130 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.